Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > MAYDAY!MAYDAY!...
View:
Post by cheetio on Apr 20, 2015 6:34am

MAYDAY!MAYDAY!...

Sell in may and go away 2014.....Bloom Burton & Co. Inc...appointed by the Agents as a selling group member.....Dundee Securities Ltd., as lead agent, Clarus Securities Inc. and Euro Pacific Canada Inc.....Agents received a cash fee equal to 7% of the gross proceeds realized by the Company...
Comment by cheetio on Apr 20, 2015 6:58am
Euro Pacific... hey the spec didn't make their toppers hey.......maybe after another round... https://www.theglobeandmail.com/globe-investor/article22576107.ece/BINARY/Top_Picks_2015_FINAL.pdf
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities